Cargando…
Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function
Objective: To gain insight into the mixed results of reported combination therapy studies conducted with levothyroxine (LT4) and liothyronine (LT3) between 1999 and 2016. Methods: We defined trial success as improved clinical outcome measures and/or patient preference for added LT3. We hypothesized...
Autores principales: | DiStefano, Joseph, Jonklaas, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873785/ https://www.ncbi.nlm.nih.gov/pubmed/31803137 http://dx.doi.org/10.3389/fendo.2019.00746 |
Ejemplares similares
-
Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design
por: Premawardhana, Lakdasa D., et al.
Publicado: (2023) -
Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life
por: Tariq, Anam, et al.
Publicado: (2018) -
Optimized Replacement T4 and T4+T3 Dosing in Male and Female Hypothyroid Patients With Different BMIs Using a Personalized Mechanistic Model of Thyroid Hormone Regulation Dynamics
por: Cruz-Loya, Mauricio, et al.
Publicado: (2022) -
Restoration of euthyroidism with levothyroxine: implications of etiology of hypothyroidism and the degree of residual endogenous thyroid function
por: Jonklaas, Jacqueline
Publicado: (2022) -
LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?
por: Azizi, Fereidoun, et al.
Publicado: (2020)